News Kenvue Inc.

Stocks

KVUE

US49177J1025

Personal Products

Market Closed - NYSE Other stock markets 04:00:02 2026-07-10 pm EDT			5-day change	1st Jan Change
19.48 ^USD	+1.56%		-1.77%	+12.93%

Jul. 07	HSBC Adjusts Price Target on Kenvue to $20 From $19	MT
Jun. 16	Mondelez Appoints Amit Banati as Chief Financial Officer

All News

Mentions Relevance

Jul. 07	HSBC Adjusts Price Target on Kenvue to $20 From $19	MT
Jun. 16	Kenvue : maker of Neutrogena®, Aveeno®, OGX®, and Zyrtec®, beats 2025 packaging goal, demonstrates continued progress with more sustainable innovation	PU
Jun. 02	Listerine Introduces Range of Mouthwash Intensities Including New Extra Mild	CI
May. 20	Greyparrot and Kenvue collaborate to help accelerate circular packaging efforts with AI-powered Material Recovery Intelligence	RE
May. 20	Greyparrot and Kenvue Collaborate to Advance Circular Packaging with Ai-Powered Material Recovery Intelligence	CI
May. 12	Kenvue Insider Sold Shares Worth $679,691, According to a Recent SEC Filing	MT
May. 07	Kenvue Inc. Reports Earnings Results for the First Quarter Ended March 29, 2026	CI
May. 07	Kenvue given dynamic nature of conditions due to Middle East conflict, expect continued variability in macroeconomic environment- SEC filing	RE
May. 07	Tranche Update on Kenvue Inc.'s Equity Buyback Plan announced on October 26, 2023.	CI
May. 07	Kenvue Fiscal Q1 Adjusted Earnings, Net Sales Rise	MT
May. 07	Kenvue beats first-quarter estimates amid pending acquisition by Kimberly-Clark	RE
May. 07	Earnings Flash (KVUE) Kenvue Inc. Reports Q1 Revenue $3.91B, vs. FactSet Est of $3.84B	MT
May. 07	Earnings Flash (KVUE) Kenvue Inc. Posts Q1 Adjusted EPS $0.32 per Share, vs. FactSet Est of $0.26	MT
May. 07	Kenvue: Q1 Earnings Snapshot	AQ
May. 07	Kenvue Reports First Quarter 2026 Results	BU
Apr. 29	Kenvue Declares Quarterly Cash Dividend	BU
Apr. 28	Kenvue Inc. announces Quarterly dividend, payable on May 27, 2026	CI
Apr. 28	Adult acne and the skin barrier: How to treat breakouts without overdrying	PU
Apr. 23	Kenvue to Announce First Quarter 2026 Results on May 7, 2026	BU
Apr. 15	Kenvue Inc. Appoints Heather Howlett as Interim Chief Financial Officer, Effective May 12, 2026	CI
Apr. 15	Kimberly-Clark Announces Post-Closing Organizational Structure and Identifies Key Leadership	PR
Apr. 15	Citigroup Adjusts Kenvue Price Target to $19 From $20, Maintains Neutral Rating	MT
Apr. 14	Barclays Adjusts Price Target on Kenvue to $18 From $19, Maintains Equalweight Rating	MT
Apr. 07	UBS Adjusts Kenvue Price Target to $18 From $19, Maintains Neutral Rating	MT
Mar. 27	Neutrogena, Aveeno And Rogaine Part of the Kenvue portfolio Debut New Dermatology Research And Clinical Skincare Innovations	CI